10 20 30 40 50 60 70 80 3DS4 - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER VIRAL PROTEIN 11-JUL-08 3DS4
TITLE HIV-1 CAPSID C-TERMINAL DOMAIN MUTANT (L211S) IN COMPLEX TITLE 2 WITH AN INHIBITOR OF PARTICLE ASSEMBLY (CAI)
COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIV-1 CAPSID PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: C-TERMINAL DOMAIN, UNP RESIDUES 278-363; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: PEPTIDE INHIBITOR OF CAPSID ASSEMBLY; COMPND 9 CHAIN: T; COMPND 10 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_COMMON: HIV-1; SOURCE 4 ORGANISM_TAXID: 11698; SOURCE 5 STRAIN: NL4-3; SOURCE 6 GENE: GAG; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3)CODONPLUS RIL; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PET11C; SOURCE 12 MOL_ID: 2; SOURCE 13 SYNTHETIC: YES; SOURCE 14 OTHER_DETAILS: CAI PEPTIDE WAS OBTAINED AS LYOPHILIZED SOURCE 15 TRIFLUOROACETIC ACID SALTS.
KEYWDS HIV, CAPSID, MUTANT, INHIBITOR, ASSEMBLY, POLYPROTEIN, KEYWDS 2 COMPLEX(VIRAL PROTEIN/PEPTIDE), MAINLY ALPHA
EXPDTA X-RAY DIFFRACTION
AUTHOR S.IGONET,M.C.VANEY,F.A.REY
REVDAT 4 24-FEB-09 3DS4 1 VERSN REVDAT 3 25-NOV-08 3DS4 1 JRNL REVDAT 2 09-SEP-08 3DS4 1 JRNL REVDAT 1 02-SEP-08 3DS4 0
JRNL AUTH V.BARTONOVA,S.IGONET,J.STICHT,B.GLASS,A.HABERMANN, JRNL AUTH 2 M.C.VANEY,P.SEHR,J.LEWIS,F.A.REY,H.G.KRAUSSLICH JRNL TITL RESIDUES IN THE HIV-1 CAPSID ASSEMBLY INHIBITOR JRNL TITL 2 BINDING SITE ARE ESSENTIAL FOR MAINTAINING THE JRNL TITL 3 ASSEMBLY-COMPETENT QUATERNARY STRUCTURE OF THE JRNL TITL 4 CAPSID PROTEIN. JRNL REF J.BIOL.CHEM. V. 283 32024 2008 JRNL REFN ISSN 0021-9258 JRNL PMID 18772135 JRNL DOI 10.1074/JBC.M804230200
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH F.TERNOIS,J.STICHT,S.DUQUERROY,H.-G.KRAUSSLICH, REMARK 1 AUTH 2 F.A.REY REMARK 1 TITL THE HIV-1 CAPSID PROTEIN C-TERMINAL DOMAIN IN REMARK 1 TITL 2 COMPLEX WITH A VIRUS ASSEMBLY INHIBITOR REMARK 1 REF NAT.STRUCT.MOL.BIOL. V. 12 678 2005 REMARK 1 REFN ISSN 1545-9993 REMARK 1 PMID 16041386 REMARK 1 DOI 10.1038/NSMB967
REMARK 2 REMARK 2 RESOLUTION. 1.12 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.12 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.40 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 3 NUMBER OF REFLECTIONS : 62969 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.209 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2022 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.12 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.15 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3416 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 70.68 REMARK 3 BIN R VALUE (WORKING SET) : 0.3170 REMARK 3 BIN FREE R VALUE SET COUNT : 111 REMARK 3 BIN FREE R VALUE : 0.2990 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1303 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 321 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.05 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.01000 REMARK 3 B22 (A**2) : -0.01000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.044 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.043 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.032 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.500 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.957 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.950 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1327 ; 0.007 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 1795 ; 1.072 ; 1.980 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 165 ; 4.238 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 62 ;30.830 ;24.677 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 237 ;11.544 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 10 ;14.197 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 196 ; 0.070 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1013 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 713 ; 0.191 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 940 ; 0.300 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 264 ; 0.118 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 61 ; 0.168 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 32 ; 0.109 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 850 ; 0.923 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1335 ; 1.364 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 541 ; 2.256 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 460 ; 2.650 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 1391 ; 1.994 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 326 ; 2.490 ; 3.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 1303 ; 2.135 ; 3.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS
REMARK 4 REMARK 4 3DS4 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-JUL-08. REMARK 100 THE RCSB ID CODE IS RCSB048418.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-MAR-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0080 REMARK 200 MONOCHROMATOR : SI(111) MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 63254 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.120 REMARK 200 RESOLUTION RANGE LOW (A) : 41.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.2 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.04800 REMARK 200 R SYM (I) : 0.04800 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.12 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.19 REMARK 200 COMPLETENESS FOR SHELL (%) : 73.3 REMARK 200 DATA REDUNDANCY IN SHELL : 5.60 REMARK 200 R MERGE FOR SHELL (I) : 0.41000 REMARK 200 R SYM FOR SHELL (I) : 0.41000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2BUO REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.02 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG4000, 200MM AMMONIUM SULFATE, REMARK 280 EVAPORATION, TEMPERATURE 298K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.63500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2350 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9090 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, T, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 146 REMARK 465 PRO A 147 REMARK 465 GLY A 225 REMARK 465 HIS A 226 REMARK 465 LYS A 227 REMARK 465 ALA A 228 REMARK 465 ARG A 229 REMARK 465 VAL A 230 REMARK 465 LEU A 231 REMARK 465 SER B 146 REMARK 465 PRO B 147 REMARK 465 THR B 148 REMARK 465 PRO B 224 REMARK 465 GLY B 225 REMARK 465 HIS B 226 REMARK 465 LYS B 227 REMARK 465 ALA B 228 REMARK 465 ARG B 229 REMARK 465 VAL B 230 REMARK 465 LEU B 231
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 188 -60.84 -103.84 REMARK 500 THR B 188 -66.37 -123.99 REMARK 500 REMARK 500 REMARK: NULL
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3DS2 RELATED DB: PDB REMARK 900 HIV-1 CAPSID C-TERMINAL DOMAIN MUTANT (Y169A) REMARK 900 RELATED ID: 3DS3 RELATED DB: PDB REMARK 900 HIV-1 CAPSID C-TERMINAL DOMAIN MUTANT (Y169A) IN COMPLEX REMARK 900 WITH AN INHIBITOR OF PARTICLE ASSEMBLY (CAI) REMARK 900 RELATED ID: 3DTJ RELATED DB: PDB REMARK 900 HIV-1 CAPSID C-TERMINAL DOMAIN MUTANT (E187A) REMARK 900 RELATED ID: 3DS1 RELATED DB: PDB REMARK 900 HIV-1 CAPSID C-TERMINAL DOMAIN MUTANT (E187A) IN COMPLEX REMARK 900 WITH AN INHIBITOR OF PARTICLE ASSEMBLY (CAI) REMARK 900 RELATED ID: 3DS5 RELATED DB: PDB REMARK 900 HIV-1 CAPSID C-TERMINAL DOMAIN MUTANT (N183A) REMARK 900 RELATED ID: 3DS0 RELATED DB: PDB REMARK 900 HIV-1 CAPSID C-TERMINAL DOMAIN MUTANT (N183A) IN COMPLEX REMARK 900 WITH AN INHIBITOR OF PARTICLE ASSEMBLY (CAI) REMARK 900 RELATED ID: 3DPH RELATED DB: PDB REMARK 900 HIV-1 CAPSID C-TERMINAL DOMAIN MUTANT (L211S)
DBREF 3DS4 A 146 231 UNP Q72497 Q72497_9HIV1 278 363 DBREF 3DS4 B 146 231 UNP Q72497 Q72497_9HIV1 278 363 DBREF 3DS4 T 1 12 PDB 3DS4 3DS4 1 12
SEQADV 3DS4 SER A 211 UNP Q72497 LEU 343 ENGINEERED SEQADV 3DS4 SER B 211 UNP Q72497 LEU 343 ENGINEERED
SEQRES 1 A 86 SER PRO THR SER ILE LEU ASP ILE ARG GLN GLY PRO LYS SEQRES 2 A 86 GLU PRO PHE ARG ASP TYR VAL ASP ARG PHE TYR LYS THR SEQRES 3 A 86 LEU ARG ALA GLU GLN ALA SER GLN GLU VAL LYS ASN TRP SEQRES 4 A 86 MET THR GLU THR LEU LEU VAL GLN ASN ALA ASN PRO ASP SEQRES 5 A 86 CYS LYS THR ILE LEU LYS ALA LEU GLY PRO GLY ALA THR SEQRES 6 A 86 SER GLU GLU MET MET THR ALA CYS GLN GLY VAL GLY GLY SEQRES 7 A 86 PRO GLY HIS LYS ALA ARG VAL LEU SEQRES 1 B 86 SER PRO THR SER ILE LEU ASP ILE ARG GLN GLY PRO LYS SEQRES 2 B 86 GLU PRO PHE ARG ASP TYR VAL ASP ARG PHE TYR LYS THR SEQRES 3 B 86 LEU ARG ALA GLU GLN ALA SER GLN GLU VAL LYS ASN TRP SEQRES 4 B 86 MET THR GLU THR LEU LEU VAL GLN ASN ALA ASN PRO ASP SEQRES 5 B 86 CYS LYS THR ILE LEU LYS ALA LEU GLY PRO GLY ALA THR SEQRES 6 B 86 SER GLU GLU MET MET THR ALA CYS GLN GLY VAL GLY GLY SEQRES 7 B 86 PRO GLY HIS LYS ALA ARG VAL LEU SEQRES 1 T 12 ILE THR PHE GLU ASP LEU LEU ASP TYR TYR GLY PRO
FORMUL 4 HOH *321(H2 O)
HELIX 1 1 SER A 149 ILE A 153 5 5 HELIX 2 2 PRO A 160 GLU A 175 1 16 HELIX 3 3 SER A 178 ASN A 193 1 16 HELIX 4 4 ASN A 195 GLY A 206 1 12 HELIX 5 5 THR A 210 GLN A 219 1 10 HELIX 6 6 PRO B 160 GLU B 175 1 16 HELIX 7 7 SER B 178 THR B 188 1 11 HELIX 8 8 THR B 188 ASN B 193 1 6 HELIX 9 9 ASN B 195 GLY B 206 1 12 HELIX 10 10 THR B 210 GLN B 219 1 10 HELIX 11 11 THR T 2 GLY T 11 1 10
CRYST1 31.510 69.270 41.550 90.00 97.66 90.00 P 1 21 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.031736 0.000000 0.004268 0.00000
SCALE2 0.000000 0.014436 0.000000 0.00000
SCALE3 0.000000 0.000000 0.024284 0.00000